Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment.
The presence of antibodies to rifampin was determined in sera of patients with tuberculosis on daily treatment one day after discontinuation of treatment, one week later, 3 weeks later, and 8 weeks later. The highest number of positive patients was found in the third week.
D000818:Animals; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D006801:Humans; D051381:Rats; D012293:Rifampin / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D013997:Time Factors; D014376:Tuberculosis / Q000097:blood / Q000188:drug therapy*
D012293:Rifampin